Literature DB >> 19562489

Studies on the effect of water-soluble polymers on drug-cyclodextrin complex solubility.

Rajashree S Hirlekar1, Suneeta N Sonawane, Vilasrao J Kadam.   

Abstract

The effect of complexation of irbesartan (IRB), a practically water-insoluble drug, with cyclodextrins in presence of different concentrations of water-soluble polymers (PEG 4000 and PVP K-90) on the dissolution rate of the drug has been investigated. Phase solubility studies were carried out to evaluate the solubilizing power of betaCD in association with water-soluble polymers towards IRB and to determine the apparent stability constant (K (S)) of the complexes. Improvement in K(S) value for ternary complexes (IRB-betaCD-polymers) clearly proved the benefit on the addition of water-soluble polymer to increase complexation efficiency. The dissolution rate of the drug from ternary systems containing PEG 4000 and PVP K-90 was higher as compared to the binary system. An optimum increase in the dissolution rate of the drug was observed at a polymer concentration of 5% w/w for PVP K-90 and 10% w/w for PEG 4000. DSC, FTIR, SEM, and XRD studies were carried out to characterize the complexes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19562489      PMCID: PMC2802171          DOI: 10.1208/s12249-009-9274-6

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  13 in total

1.  A comparative assessment of solubility advantage from glassy and crystalline forms of a water-insoluble drug.

Authors:  Garima Chawla; Arvind K Bansal
Journal:  Eur J Pharm Sci       Date:  2007-06-02       Impact factor: 4.384

Review 2.  Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization.

Authors:  T Loftsson; M E Brewster
Journal:  J Pharm Sci       Date:  1996-10       Impact factor: 3.534

Review 3.  Cyclodextrins in drug delivery: an updated review.

Authors:  Rajeswari Challa; Alka Ahuja; Javed Ali; R K Khar
Journal:  AAPS PharmSciTech       Date:  2005-10-14       Impact factor: 3.246

Review 4.  Clinical overview of irbesartan: a new angiotensin II receptor antagonist.

Authors:  H G Pouleur
Journal:  Am J Hypertens       Date:  1997-12       Impact factor: 2.689

Review 5.  Cyclodextrins and their pharmaceutical applications.

Authors:  Thorsteinn Loftsson; Dominique Duchêne
Journal:  Int J Pharm       Date:  2006-11-09       Impact factor: 5.875

6.  Implication of inclusion complexation of glimepiride in cyclodextrin-polymer systems on its dissolution, stability and therapeutic efficacy.

Authors:  H O Ammar; H A Salama; M Ghorab; A A Mahmoud
Journal:  Int J Pharm       Date:  2006-04-18       Impact factor: 5.875

7.  Effect of PVP K-25 on the formation of the naproxen:beta-ciclodextrin complex.

Authors:  Margarita Valero; Blanca I Pérez-Revuelta; Licesio J Rodríguez
Journal:  Int J Pharm       Date:  2003-03-06       Impact factor: 5.875

8.  Physicochemical investigation of the effects of water-soluble polymers on vinpocetine complexation with beta-cyclodextrin and its sulfobutyl ether derivative in solution and solid state.

Authors:  Laura S S Ribeiro; Domingos C Ferreira; Francisco J B Veiga
Journal:  Eur J Pharm Sci       Date:  2003-11       Impact factor: 4.384

Review 9.  The utility of cyclodextrins for enhancing oral bioavailability.

Authors:  Rebecca L Carrier; Lee A Miller; Imran Ahmed
Journal:  J Control Release       Date:  2007-08-16       Impact factor: 9.776

Review 10.  Cyclodextrins as pharmaceutical solubilizers.

Authors:  Marcus E Brewster; Thorsteinn Loftsson
Journal:  Adv Drug Deliv Rev       Date:  2007-05-29       Impact factor: 15.470

View more
  7 in total

1.  Enhanced solubility and intestinal absorption of candesartan cilexetil solid dispersions using everted rat intestinal sacs.

Authors:  S Gurunath; Baswaraj K Nanjwade; P A Patila
Journal:  Saudi Pharm J       Date:  2013-04-08       Impact factor: 4.330

2.  Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.

Authors:  Kale Mohana Raghava Srivalli; Brahmeshwar Mishra
Journal:  AAPS PharmSciTech       Date:  2015-06-16       Impact factor: 3.246

3.  Formulation and Evaluation of Supramolecular Food-Grade Piperine HP β CD and TPGS Complex: Dissolution, Physicochemical Characterization, Molecular Docking, In Vitro Antioxidant Activity, and Antimicrobial Assessment.

Authors:  Syed Sarim Imam; Sultan Alshehri; Talal Abdullah Alzahrani; Afzal Hussain; Mohammad A Altamimi
Journal:  Molecules       Date:  2020-10-14       Impact factor: 4.411

4.  Implementing polymeric pseudorotaxanes for boosting corneal permeability and antiaspergillus activity of tolnaftate: formulation development, statistical optimization, ex vivo permeation and in vivo assessment.

Authors:  Diana Aziz; Sally Mohamed; Saadia Tayel; Amal Makhlouf
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

5.  Improvement of solubility and dissolution properties of clotrimazole by solid dispersions and inclusion complexes.

Authors:  Gehan Balata; M Mahdi; Rania Abu Bakera
Journal:  Indian J Pharm Sci       Date:  2011-09       Impact factor: 0.975

6.  In Vitro and Ex Vivo Evaluation of Nepafenac-Based Cyclodextrin Microparticles for Treatment of Eye Inflammation.

Authors:  Blanca Lorenzo-Veiga; Patricia Diaz-Rodriguez; Carmen Alvarez-Lorenzo; Thorsteinn Loftsson; Hakon Hrafn Sigurdsson
Journal:  Nanomaterials (Basel)       Date:  2020-04-09       Impact factor: 5.076

7.  Solubility enhancement of mefenamic acid by inclusion complex with β-cyclodextrin: in silico modelling, formulation, characterisation, and in vitro studies.

Authors:  Dounia Sid; Milad Baitiche; Zineb Elbahri; Ferhat Djerboua; Mokhtar Boutahala; Zouhair Bouaziz; Marc Le Borgne
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.